jc
jc

News Center

Check category
/
/
/
Powerful, global leader! Jie Cheng medical intervention in artificial biological heart valve system listed

Powerful, global leader! Jie Cheng medical intervention in artificial biological heart valve system listed

  • Categories:News Channel
  • Author:
  • Origin:
  • Time of issue:2017-06-08 14:27
  • Views:

(Summary description)

Powerful, global leader! Jie Cheng medical intervention in artificial biological heart valve system listed

(Summary description)

  • Categories:News Channel
  • Author:
  • Origin:
  • Time of issue:2017-06-08 14:27
  • Views:
Information

  Heart failure has become the world's first major cause of death! There are 12 million heart valve patients around the world, each year nearly 100 million people died.
  Traditional surgery "block" 2/3 patients
  June 8, Suzhou Jincheng Medical Technology held in Beijing, "J-Valve? Involved in artificial bio-valve" conference, which is China's first original and has a leading international intellectual property involved in heart valves, is currently the world's only effective micro A treatment of aortic valve insufficiency or stenosis of the solution.

  Valve is a door of the heart, only the door smoothly open and close, smooth, the heart can be healthy and effective blood supply, once the valve stenosis or can not be closed, the heart will be lack of power failure.

  China is a high incidence of heart valve disease, more than 2 million patients, patients need surgery every year in more than 200,000. But really can receive surgery but less than 1/3, China has 150,000 patients lost surgery every year.

 

X

 

  Chinese Academy of Medical Sciences Fu Wai Hospital, Department of Cardiac Surgery, Professor Wang Wei, director of minimally invasive center
  "At present the world's common and traditional valve treatment is through the traditional replacement of heart valve surgery, namely: thoracotomy, cut heart, cardiopulmonary bypass, cardiac arrest, suture the valve. Need under the neck, chest out 30 cm long Incision, the doctor manually replace the valve, surgery for up to 3 to 4 hours, the patient needs to endure great pain and blood loss. "Chinese Academy of Medical Sciences Fu Wai Hospital, director of the Department of Cardiac Surgery, Wang Wei pointed out.

  "This is not only the question of money, the situation in the world is the same. Limited medical conditions and patients on the surgery to accept the ability to be mutual." To overcome the heart valve disease problems, Suzhou Jincheng Medical Technology Co., Ltd. founder Zhang Dr. Dr. spent 37 years to study the heart.


  To overcome the world problems
  In 2009, Dr. Zhang returned to his own valve replacement technology research results back to the motherland, and then changed the five technical products. "Is now the sixth generation, and successfully completed more than 100 cases of clinical case therapy."

 

S

 

  "J-Valve heart valve" patent inventor Dr. Zhang pole handheld J-Valve to explain to the guests
  Recently, the State Food and Drug Administration issued a notice, Suzhou Jincheng Medical Technology Co., Ltd. production of innovative products, "J-Valve? involved in artificial bio-valve" was approved for listing, and access to approval "products for patients with aortic stenosis, the main Patients with arterial insufficiency, or patients with both coexistence. " This is China's first original and has a leading international intellectual property involved in heart valves, is currently the only effective minimally invasive treatment of aortic valve regurgitation or stenosis of the solution.

  Heart valve disease, one is mainly stenosis, one is off the main. Previous heart valve minimally invasive products can only be used in patients with narrow, J-Valve? heart valve technology because of the unique design of separate positioning keys, it can treat aortic valve insufficiency.

  At present, the United States listed two minimally invasive heart valve implant system, but there is no comprehensive positioning device. "With the positioning device of the heart valve implant system", which is J-Valve ? interventional artificial bio-valve is another feature, is currently the world's only intelligent positioning of the three heart valve system. To avoid the traditional thoracic surgery malpractice, no surgery, surgery time is short, simple operation process, relying on the implantation of the system itself to complete the valve positioning device replacement surgery, reducing the risk of surgery.


  Replacement surgery is only 7 to 10 minutes
  At the conference site, Prof. Guo Yingjiang from Huaxi Hospital of Sichuan University shared the "J-Valve? Clinical Research Achievements in China". As of May 2017, successively in the West China Hospital of Sichuan University, Shanghai Fudan University Affiliated Zhongshan Hospital, Chinese Academy of Medical Sciences Fu Wai Hospital Hospital of cardiovascular disease, have completed more than 100 cases of clinical trials.

 

X

 

  "J-Valve? Interventional Biofilm System" has been successfully launched
  Clinical data show that only 12 months after the all-cause mortality rate of only 5.6%, permanent pacemaker implantation rate of only 4.6%, far below the global average. Research results published in the international top academic journal "American Heart Association" on.
   
  As the world's most advanced valve disease treatment technology, the use of this technique for aortic valve replacement takes only 7 to 10 minutes, the fastest can reach 2 minutes, and clinical trials are high-risk elderly patients, the average age of 74 Years old, the highest age of 87 years old.

Contact us

这是描述信息

+86-512-63179788(WJ) | +86-512-63036288(SZ)

这是描述信息

Building4-1,Hi-Tech Park, Wujiang, Jiangsu Province, China

C21 Building, 218 Xinghu Street, Suzhou Industrial Park, China

这是描述信息

215200

FOLLOW US

这是描述信息

Mobile Website

这是描述信息

WeChat

Copyright ©  Suzhou Jiecheng Medical Technology Co., Ltd. 

这是描述信息